Very excited to publish part of my thesis work!!! Some evidence for plasticity and metaplasticity following psychedelic administration in an ex vivo model.

Paper by our very own Dr. Zarmeen Zahid 💞

So happy to be here 🥰🤓

Happy to add to the conversation on psychedelics and plasticity with our new publication assessing the effects of DOI on hippocampal plasticity in an ex vivo model. Check it out! liebertpub.com/doi/10.1089/ps…

New Neuropsychopharmacology paper from Dr. Rebecca Boehme The Boehme Lab Reinoud Kaldewaij @pausalamone Adam Enmalm @csan_liu Ketamine⬇️activity associated w/ self-other- touch distinction in right temporoparietal ctx, a region involved in touch perception & social cognition nature.com/articles/s4138…

me researching: haha fuck yeah!!! yes!! me arranging that research into coherent prose: well this fucking sucks. what the fuck.

If you're in town, drop by! I hear it should be a good talk?? 😌

The International Society for Research on Psychedelics is looking for volunteers for their Trainee Seminar Series ✨ The format of these presentations is 45 min followed by 15 min Q&A. Invitations to present will be sent out by September 1st 2024. docs.google.com/forms/d/e/1FAI…

Are you a clinician studying psychedelics for trauma disorders like PTSD? Do you want to chat about your study on our podcast? Do you want to explain the reason why psychedelics might work? Please contact us on Twitter or via our website 🤓

“we will work with external experts on an independent advisory board, focus our initial commercial rollout on centers of care where there are multiple layers of oversight and collaborate with others around therapy training.”

We’ve got some really cool guests coming up on Season 4 of Your Brain on Science! subscribe to our podcast & turn on those notifications for episode drops! #yourbrainonscience #ybos #psychedelics #psychedelicbrainscience #psychedelicscience

A big decision came down today from the FDA on Lykos Therapeutics drug application for MDMA-assisted therapy to treat PTSD. This would have been the first psychedelic to be FDA approved, despite it being a schedule I substance. What are your thoughts? #mdma #ptsd #fda #lykos

Wow! The snowball effect? Or just bad timing for Lykos/MAPS? Psychopharmacology has posted retraction notices for any papers related to MAPS MP4 misconduct in Phase 2 clinical trials. This comes after a lot of time and effort by Sasha Sisko to bring attention to these events.

Thanks everyone for your enthusiasm at our first episode of season 4! We’ve reached 100 listens in just 7 days 🤩 If you haven’t listened yet or forgot to rate and share the podcast pls do so! We ❤️ you ! #psychedelicbrainscience #yourbrainonscience open.spotify.com/episode/4771Nu…

🔬Our new paper in Nature Reviews Psychology outlines the limitations of our understanding of psychedelics' subjective effects & how we can improve our science moving forward, going beyond just mystical experience. Proud to be a part of this with David B. Yaden, Brandon, & Roland Griffiths.

Couldn’t be more excited! 🎊

very excited that Dr. Zarmeen Zahid is now Johns Hopkins Psychedelic Research Center !

New article: Quantitative summary of adverse events in psychedelic studies. We find a favorable safety profile, but with major caveats. Serious adverse events were rare but did occur (esp. in those w/ disorders). We call for improvements to adverse event recording and reporting.

New paper published in JAMA Psychiatry: A meta-analysis of adverse events in trials of classic psychedelics suggests an overall favorable safety profile. However, serious adverse events, while rare, did occur. It highlights ways to improve the detection and reporting of adverse events